dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

 

Rad Oncology Homepage

Four considerations before embarking on a carbon therapy center The next frontier in improving cancer care

Q & A with Scott Warwick, executive director of the National Association for Proton Therapy Find out what to expect at the year's biggest proton therapy industry event

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

Aussies and Americans develop 3D models for assessing impacts of radiotherapy Test different levels and types of radiation

Law in Ontario prevents cremation of brachytherapy patients Experts call for eliminating the law, as it deters patients from lifesaving treatment

Access to proton therapy increasing for pediatric patients Young cancer patients have the most to gain from proton treatment

Public-private partnership replaces 50-year old radiotherapy equipment in Guatemala Upgrading to Varian Halcyon system

Hypofractionated radiotherapy no worse than conventional RT, says study No difference in progression and survival

Proton therapy market continues decline after 2015 high point: report By comparison, investment in 2018 dropped 62 percent

FDA approves Mirada Medical's Simplicit90Y Dosimetry software Speeding up planning and workflow for Y90 TransArterial Radioembolization

The first Flash irradiation demonstration
with IBA technology took place at
University Medical Centre Groningen in
The Netherlands

IBA tech plays first-time role in flash therapy demonstration

John R. Fischer , Staff Reporter
The first Flash irradiation demonstration performed with IBA technology took place this month at the University Medical Centre Groningen (UMCG) in The Netherlands.

Researchers at the Dutch-based institute performed the practice in an IBA gantry treatment room, marking a step forward for IBA and its medical and research partners in integrating Flash irradiation as a clinical treatment.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“Being the first proton therapy center that has treated patients in The Netherlands, we have the vision that the clinical introduction of new and emerging radiation technologies should be more evidence-based,” said Hans Langendijk, chair of radiation oncology at UMCG, in a statement. “As the pioneer of the model-based approach for selecting patients for proton therapy in The Netherlands, we look forward to better understand the radiobiological effect of Flash irradiation and predict the benefits and outcomes of Flash therapy for patients.”

A noninvasive radiotherapy technique, Flash irradiation delivers high doses at ultra-high speeds in less than one second, saving time on, and prolonged exposure to, radiation during procedures. The phenomenon requires a dose superior to 8 Gy and a dose rate above 33 Gy/sec, compared to conventional dose rates for radiotherapy which are 1-7 cGy/sec. It is theorized that the high dose rate depletes the oxygen within tissues, rendering healthy ones radioresistant and allowing dose to reach levels that destroy tumor tissues, even in high hypoxia, with almost no impact on healthy surrounding tissue.

The demonstration, which took place on March 1, consisted of several Flash irradiations delivered at the isocenter of one of the facility’s two gantry treatment rooms. Using IBA Proteus solution, researchers obtained positive results that exceed the conditions required for the Flash effect with a dose rate up to 200 Gy/sec.

It follows a number of events revolving around the practice, including funding for two accelerator-based projects in X-ray and proton therapy at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University, respectively; and the launch of Varian’s ProBeam 360° platform, which is expected to open access to flash therapy and other potential next-generation treatments.

“We are excited about the recent results obtained in Groningen, demonstrating IBA’s technology leadership in Flash therapy research, a novel technique that has the potential to change the way patients are treated,” said Olivier Legrain, chief executive officer at IBA, in a statement. "Building on a unique and open culture of collaborative innovation, IBA continues its commitment to further develop Flash therapy by partnering with the largest and most experienced user community in studying the radiobiology of proton Flash irradiation and help our clinical partners move faster to bring value to the clinic.”

Back to HCB News
  Pages: 1

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有